UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Lenalidomide and dexamethasone for acute light chain-induced renal failure: a phase II study

Haematologica (Roma), 2015-03, Vol.100 (3), p.385-391

2015

Volltextzugriff (PDF)

Detection of Circulating Mammary Carcinoma Cells in the Peripheral Blood of Breast Cancer Patients Via a Nested Reverse Transcriptase Polymerase Chain Reaction Assay for Mammaglobin mRNA

Journal of clinical oncology, 1999-07, Vol.17 (7), p.2015-2019

1999

Volltextzugriff (PDF)

Bendamustine-bortezomib-dexamethasone is an active and well-tolerated regimen in patients with relapsed or refractory multiple myeloma

Blood, 2014-02, Vol.123 (7), p.985-991

2014

Volltextzugriff (PDF)

Total body irradiation with volumetric modulated arc therapy: Dosimetric data and first clinical experience

Radiation oncology (London, England), 2016-03, Vol.11 (1), p.46, Article 46

2016

Volltextzugriff (PDF)

Double-Blind, Randomized, Placebo-Controlled Multi-Center Phase III Study Followed by Open-Label Phase on the Efficacy and Tolerability of Budesonide in Patients with Resistant Oral Chronic GVHD: Part 2 – Pain, Subjective Measures and Safety Analysis

Oral surgery, oral medicine, oral pathology and oral radiology, 2023-02, Vol.135 (2), p.e43-e44

2023

Volltextzugriff (PDF)

Double-Blind, Randomized, Placebo-Controlled Multi-Center Phase III Study Followed By Open-Label Phase on the Efficacy and Tolerability of Budesonide in Patients with Resistant Oral Chronic GVHD: Part 1 - Efficacy Analysis

Oral surgery, oral medicine, oral pathology and oral radiology, 2023-02, Vol.135 (2), p.e42-e43

2023

Volltextzugriff (PDF)

Clinical significance of HLA-E0103 homozygosity on survival after allogeneic hematopoietic stem-cell transplantation

Transplantation, 2009-08, Vol.88 (4), p.528-532

2009

Volltextzugriff (PDF)

Lenalidomide and Dexamethasone for Acute Light Chain-Induced Renal Failure: Final Results of a Phase II Study

Blood, 2014-12, Vol.124 (21), p.3484-3484

2014

Volltextzugriff (PDF)

Plerixafor and granulocyte-colony-stimulating factor (G-CSF) in patients with lymphoma and multiple myeloma previously failing mobilization with G-CSF with or without chemotherapy for autologous hematopoietic stem cell mobilization: the Austrian experience on a named patient program

Transfusion (Philadelphia, Pa.), 2011-05, Vol.51 (5), p.968-975

2011

Volltextzugriff (PDF)

Significant Activity of Lenalidomide-Dexamethasone in Multiple Myeloma (MM) Patients with Light Chain Induced Acute Renal Failure (LC-ARF)

Blood, 2012-11, Vol.120 (21), p.4031-4031

2012

Volltextzugriff (PDF)

Treatment with Bendamustine-Bortezomib-Dexamethasone (BBD) in Relapsed/Refractory Multiple Myeloma Shows Significant Activity and Is Well Tolerated

Blood, 2012-11, Vol.120 (21), p.943-943

2012

Volltextzugriff (PDF)

Response: Significant influence of LCT-13910C>T on transplantation outcomes in acute myeloid leukemia patients receiving transplantations from HLA-identical sibling donors

Blood, 2010-04, Vol.115 (17), p.3645-3646

2010

Volltextzugriff (PDF)

Bortezomib-Bendamustine-Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma (MM) Shows Marked Efficacy and Is Well Tolerated, but Assessment of PNP Symptoms Shows Significant Discrepancies Between Patients and Physicians

Blood, 2011-11, Vol.118 (21), p.2928-2928

2011

Volltextzugriff (PDF)

HLA-C KIR-Ligands Determine the Impact of Anti-Thymocyte Globulin (ATG) on Graft versus Host and Graft versus Leukemia Effects Following Hematopoietic Stem Cell Transplantation

Biomedicines, 2017-03, Vol.5 (2), p.13

2017

Volltextzugriff (PDF)

A single nucleotide polymorphism at chromosome 2q21.3 (LCT −13910C>T) associates with clinical outcome after allogeneic hematopoietic stem cell transplantation

Blood, 2008-09, Vol.112 (5), p.2156-2159

2008

Volltextzugriff (PDF)

Double Transplantation with Melphalan (200 mg/m2) Compared with Triple Transplantation with Intermediate Dose Melphalan (100 mg/m2) in Patients with Multiple Myeloma

Blood, 2008-11, Vol.112 (11), p.3317-3317

2008

Volltextzugriff (PDF)

Prospective, Randomized Comparison between Double Transplantation (T) with Melphalan (200 mg/m2) and Triple T with Intermediate Dose Melphalan (100 mg/m2) in Patients with Multiple Myeloma (An Interim Analysis)

Blood, 2006-11, Vol.108 (11), p.3083-3083

2006

Volltextzugriff (PDF)

Mammaglobin as a Marker for the Detection of Tumor Cells in the Peripheral Blood of Breast Cancer Patients

Annals of the New York Academy of Sciences, 2000-12, Vol.923 (1), p.343-345

2000

Volltextzugriff (PDF)

Long-term results of autologous stem cell transplantation for Hodgkin's disease (HD) and low-/intermediate-grade B non-Hodgkin's lymphoma (NHL): a report from the Austrian Stem Cell Transplantation Registry (ASCTR)

Annals of hematology, 2005-07, Vol.84 (7), p.462-473

2005

Volltextzugriff (PDF)

Restoration of all-trans retinoic acid sensitivity by interferon in acute promyelocytic leukaemia

The Lancet (British edition), 1991-11, Vol.338 (8775), p.1154-1155

1991

Volltextzugriff (PDF)

Factors influencing the timing of peripheral blood stem cell collection (PBSC)

Transfusion science, 1996-12, Vol.17 (4), p.595-600

KASPARU, H

1996

Volltextzugriff (PDF)

Factors influencing the timing of peripheral blood stem cell collection (PBSC)

Transfusion science, 1996-12, Vol.17 (4), p.595-600

1996

Volltextzugriff (PDF)

1 – 22 von 22

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(22)
Mit Volltextzugriff
(20)

Publikationsform

Artikel
(22)

Sprache

Englisch
(22)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(12)
Science & Technology
(12)
Humans
(11)
Adult
(10)
Middle Aged
(10)
Female
(9)
Hematology
(8)
Male
(8)
Aged
(6)
Biological And Medical Sciences
(4)
Medical Sciences
(4)
Adolescent
(3)
Aged, 80 And Over
(3)
Hematopoietic Stem Cell Transplantation
(3)
Multiple Myeloma - Drug Therapy
(3)
Transplantation
(3)
Transplantation, Autologous
(3)
Young Adult
(3)
Acute Disease
(2)
Austria
(2)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Lenalidomide and dexamethasone for acute light chain-induced renal failure: a phase II study

Detection of Circulating Mammary Carcinoma Cells in the Peripheral Blood of Breast Cancer Patients Via a Nested Reverse Transcriptase Polymerase Chain Reaction Assay for Mammaglobin mRNA

Bendamustine-bortezomib-dexamethasone is an active and well-tolerated regimen in patients with relapsed or refractory multiple myeloma

Total body irradiation with volumetric modulated arc therapy: Dosimetric data and first clinical experience

Double-Blind, Randomized, Placebo-Controlled Multi-Center Phase III Study Followed by Open-Label Phase on the Efficacy and Tolerability of Budesonide in Patients with Resistant Oral Chronic GVHD: Part 2 – Pain, Subjective Measures and Safety Analysis

Double-Blind, Randomized, Placebo-Controlled Multi-Center Phase III Study Followed By Open-Label Phase on the Efficacy and Tolerability of Budesonide in Patients with Resistant Oral Chronic GVHD: Part 1 - Efficacy Analysis

Clinical significance of HLA-E0103 homozygosity on survival after allogeneic hematopoietic stem-cell transplantation

Lenalidomide and Dexamethasone for Acute Light Chain-Induced Renal Failure: Final Results of a Phase II Study

Plerixafor and granulocyte-colony-stimulating factor (G-CSF) in patients with lymphoma and multiple myeloma previously failing mobilization with G-CSF with or without chemotherapy for autologous hematopoietic stem cell mobilization: the Austrian experience on a named patient program

Significant Activity of Lenalidomide-Dexamethasone in Multiple Myeloma (MM) Patients with Light Chain Induced Acute Renal Failure (LC-ARF)

Treatment with Bendamustine-Bortezomib-Dexamethasone (BBD) in Relapsed/Refractory Multiple Myeloma Shows Significant Activity and Is Well Tolerated

Response: Significant influence of LCT-13910C>T on transplantation outcomes in acute myeloid leukemia patients receiving transplantations from HLA-identical sibling donors

Bortezomib-Bendamustine-Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma (MM) Shows Marked Efficacy and Is Well Tolerated, but Assessment of PNP Symptoms Shows Significant Discrepancies Between Patients and Physicians

HLA-C KIR-Ligands Determine the Impact of Anti-Thymocyte Globulin (ATG) on Graft versus Host and Graft versus Leukemia Effects Following Hematopoietic Stem Cell Transplantation

A single nucleotide polymorphism at chromosome 2q21.3 (LCT −13910C>T) associates with clinical outcome after allogeneic hematopoietic stem cell transplantation

Double Transplantation with Melphalan (200 mg/m2) Compared with Triple Transplantation with Intermediate Dose Melphalan (100 mg/m2) in Patients with Multiple Myeloma

Prospective, Randomized Comparison between Double Transplantation (T) with Melphalan (200 mg/m2) and Triple T with Intermediate Dose Melphalan (100 mg/m2) in Patients with Multiple Myeloma (An Interim Analysis)

Mammaglobin as a Marker for the Detection of Tumor Cells in the Peripheral Blood of Breast Cancer Patients

Long-term results of autologous stem cell transplantation for Hodgkin's disease (HD) and low-/intermediate-grade B non-Hodgkin's lymphoma (NHL): a report from the Austrian Stem Cell Transplantation Registry (ASCTR)

Restoration of all-trans retinoic acid sensitivity by interferon in acute promyelocytic leukaemia

Factors influencing the timing of peripheral blood stem cell collection (PBSC)

Factors influencing the timing of peripheral blood stem cell collection (PBSC)

Suchergebnisse filtern